In our recent experience most children with coeliac disease (CD) now present and are diagnosed before the age of one year (McNeish and Anderson, 1974) (Fig. 1) . At this age the clinical and labora- tory findings of CD, including jejunal histology, may be mimicked by secondary disaccharidase deficiency following gastroenteritis (Burke, Kerry, Received 20 September 1974. and Anderson, 1965) , or cow's milk protein intolerance (Visakorpi, Immonen, and Kuitunen, 1967) . The apparent improvement of a 'coeliac' infant on a gluten-free diet may represent fortuitous recovery from one of these temporary conditions. It is therefore desirable to confirm the persistence of true gluten intolerance in these 'coeliac' infants before recommending a life-long gluten-free diet. We have found the one-hour blood xylose test (Rolles et al., 1973) to be a reliable index of malabsorption in childhood CD. We have now assessed the usefulness of this test, before and after gluten challenge, as an indicator of continuing gluten sensitivity.
Patients and methods Patients. We studied 16 children who were diagnosed as having CD when aged 3-11 months, and who were 6-68 months old at the time of the present investigation. Initially each had steatorrhoea, failure to thrive, and flat jejunal mucosa. All 14 children who had a one-hour blood xylose test had an abnormal result of <20 mg/100 ml. All 16 children apparently responded symptomatically to a gluten-free diet. In 5 children clinical improvement was not obvious until after 7-10 days; 4 of these were severely ill, and the clinical and biochemical features were those of coeliac crisis, so that each infant was given a course of steriods.
The children remained on a gluten-free diet until they were readmitted to hospital for further investigation. The duration of gluten withdrawal ranged from one month to 5 years.
'Prechallenge' investigations. All 16 children had blood xylose tests on 2 consecutive days. The methods have been described previously; a normal value is more than 20 mg xylose/100 ml blood one hour after 5 g oral D-xylose (Rolles et al., 1973 Confirming persistence ofgluten intolerance in children responded at 2-7 days had been on a gluten-free diet for 2-10 months (mean 6 -7 m), while those who responded at 14-28 days had a gluten-free diet for 12-60 months (mean 30 m).
Jejunal histology. 10 children had a jejunal biopsy before the gluten challenge. In 7 the histology was normal; in 2 there was partial but incomplete mucosal regeneration; in 1 biopsy (Case 5) there were fused, stunted vifli, only slightly improved when compared to the patient's original untreated biopsy.
The 5 children who were challenged with gluten for 14 days or longer had a biopsy at the end of the challenge. In 4 (Cases 12-15) the mucosa had reverted to the classic flat picture seen in untreated CD. In Case 16 the mucosa remained normal; this child is discussed below.
Clinical effects of challenge. 11 children were asymptomatic throughout the investigation. Case 4 developed moderately severe diarrhoea and vomiting within 4 hours of the first dose of 10 g gluten. No further gluten was given, and the child was clinically normal the next day, though xylose absorption remained low for a further 2 days. This child was one of the youngest to be challenged (aged 6 months). Case 5 had two bulky motions after the first two doses of gluten, Cases 2 and 6 had mild diarrhoea, and Case 11 developed anorexia on day 10.
Case 16. This girl was diagnosed as having coeliac disease at the age of 4 months. She had steatorrhoea, xylose malabsorption, and severe enteropathy (Fig. 3) . No pathogens were isolated from her stools. At the time of diagnosis she was severely ill and had intravenous fluids and steroids for a few days. She progressed slowly for the next 10 days, when Esch. coli 0114 was isolated from her stools. Gentamicin was given orally and parenterally and she made a steady and sustained recovery. After one year on a gluten-free diet she had a gluten challenge lasting 3 months without ill effects. She returned to a normal diet and has thrived since. Intestinal biopsies obtained 3, 6, and 18 months after gluten reintroduction were all normal.
Discussion
In the past few years infants with CD have presented at a progressively earlier age, so that the majority are under 1 year at diagnosis, and 10-15% are less than 6 months old (McNeish and Anderson, 1974) (Fig. 1) and secondary disaccharidase deficiency (Burke et al., 1965) , as well as coeliac disease. In all three conditions there may be steatorrhoea, reducing substances in the stools, low levels of serum iron and folate, and severe mucosal changes in the jejunum (Anderson, 1966; Liu et al., 1968) . Furthermore, the conditions may overlap or coexist, since cow's milk protein intolerance has been found in children later shown to have CD and lactose intolerance is a known complication of CD (Arthur et al., 1966; McNeish and Sweet, 1968) . Lastly, a condition of temporary gluter. intolerance probably exists (Walker-Smith, 1970 ), though few convincing cases have been described.
A satisfactory clinical, biochemical, and histological response to a gluten-free diet is now part of the widely accepted definition of childhood CD (Meeuwisse, 1970) . Spontaneous recovery of all these parameters may also occur in the temporary states of cow's milk protein intolerance or secondary disaccharidase deficiency. If infants with these conditions are erroneously thought to have CD, a gluten-free diet may be needlessly continued indefinitely. Gluten challenge in such children seems justifiable and even desirable.
The regimen of gluten reintroduction has varied widely. Some workers have simply reintroduced a normal diet (McNeish, 1968; Shmerling, 1969; Walker-Smith, 1970 ) for up to 61 years. The variation in time required to induce a clinical or histological relapse may vary in part because the gluten content of a 'normal' diet varies considerably among individuals. In an attempt to standardize the challenge procedure, Hamilton and McNeill (1972) used one slice of bread a day (approximately 2 -25 g gluten) as a 'small uniform dose' for periods of up to 15 months.
In adults the dosage of gluten also varies widely, from 20-30 g (Bayless and Swanson, 1964; Weinstein, 1974) to as much as 100-150 g/day (Levine et al., 1966) used for up to 8 weeks to assess gluten toxicity. Levine states that (for adults), 'As a screening test for gluten toxicity a 100 g gluten "cocktail" was found to be as practical and well tolerated as lower doses previously used by others'.
We felt justified in giving a relatively large dose of 20 g gluten/day to children in order to induce a definitive change in the shortest time. This approach produced no more clinical morbidity than was reported by Hamilton and McNeill (1972) , who gave only 2 -25 g gluten daily. By adding a known amount of powdered gluten to an otherwise glutenfree diet we have also avoided accustoming our patients to the taste of ordinary gluten-containing foods which might be subsequently forbidden again.
There has been no uniformity among authors in selecting criteria for a relapse of CD after gluten reintroduction. A positive response has been defined as the appearance of clinical symptoms (Sheldon, 1959; ; the appearance of antibodies to gluten in the serum (Pelkonen and Visakorpi, 1970) ; the appearance of circulating immune complexes in the serum (Doe, Booth, and Brown, 1973) ; IgA deposition in the basement membrane of the jejunal epithelium (Shiner and Ballard, 1972) ; and the reappearance of villous atrophy in the small intestine (McNeish, 1968; Shmerling, 1969; Hamilton and McNeill, 1972) . The full diagnostic criteria suggested by the European Society of Paediatric Gastroenterology (Meeuwisse, 1970 ) require a minimum of 3 intestinal biopsies, though in fact these criteria are often not fulfilled in published descriptions of coeliac disease by reputable workers.
A practical difficulty arises when trying to meet these diagnostic requirements in young infants because their symptomatic response to gluten reintroduction may be very rapid. The histological changes in the jejunal mucosa at this time may be mild, or difficult to interpret, in the current state of knowledge. This aspect is being investigated further. In the present study we have fulfilled the ESPGA criteria in those cases which were able to tolerate gluten for 2 weeks or more.
Of the children we investigated, 15 showed a definite fall in the one-hour blood level 1-28 days after gluten challenge. This fall tended to appear most quickly in those cases which had been on a gluten-free diet for less than 6 months, and who not surprisingly had residual histological abnormalities in the jejunum (Table) . However, it is noteworthy that xylose malabsorption was rapidly produced in several children (Cases 7-10) who had been on a gluten-free diet for 7-10 months, even when the prechallenge jejunal histology was known to be normal (Cases 7 and 8).
Functional relapse took longest in the 3 children who had been treated for several years. An abnormal blood xylose test was found within 28 days in these cases, by which time severe villous atrophy had reappeared in the jejunum. It is possible that children who have been even longer on a gluten-free diet may relapse more slowly after gluten reintroduction, and our preliminary observations have tended to confirm this.
The clinical effects of gluten challenge were generally mild or absent. The only infant who had moderate symptoms was the youngest to have a gluten challenge. In retrospect, it would have been wiser to delay his challenge until he had been on a gluten-free diet for a longer period. Case 1 had been on a gluten-free diet for only 1 month when challenged. This was probably too brief a period to exclude the possibility of a temporary gluten intolerance. Case 16 showed no abnormality of xylose absorption after prolonged gluten challenge, and subsequent follow-up suggests that she does not have CD. It can be argued that her jejunal mucosa may yet relapse morphologically after more than 18 months of ingesting gluten (Shmerling, 1969) . A more likely explanation is that she had an enteropathy associated with infection, with or without temporary gluten intolerance.
From our data, we suggest that gluten challenge of'coeliac' infants should be performed 6-12 months after the onset of treatment, when they are clinically well, but not before the age of one year.
The basic defect in CD is still unknown. Until it is discovered, the diagnosis of CD will continue to be based on the clinical, biochemical, and histological consequence of gluten withdrawal and reintroduction. We suggest that the procedure described in this paper may help to increase the accuracy of diagnosis in young infants.
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